Lawrence Karsh, MD, FACS

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Astellas
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Bayer
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Bristol Myers Squibb
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Janssen
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Dendreon
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    Astra-Zeneca
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    QED
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Scientific Study or Trial (Oncology)
    Ineligible company:
    Genomic Health
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    ABBVIE
    Date added:
    Date updated:
    09/14/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consultant or Advisor (Oncology)
    Ineligible company:
    UroGPO
    Date added:
    Date updated:
    09/14/2023

Pages

Return to What's New in the Management of Hormone Naïve & Castrate Resistant Prostate Cancer: A Case-based Session for Urologists, Advanced Practice Providers and Teams Webcast (2021)